Vertex Pharmaceuticals just added more than $6b to its market cap after the announcement of a phase II trial result.
Will BOTA have the similar outcome when it announces positive Lani phase II trial result or Vapendavir phase III result (suppose biota goes with it alone)?
Add to My Watchlist
What is My Watchlist?